Curative Biotechnology, Inc. filed its DRS on Nov 24, 2021 for the period ending Dec 31, 2020. In this report its auditor, Daszkal Bolton LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0155 USD | -10.78% | -18.29% | -27.11% |
05-06 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
1st Jan change | Capi. | |
---|---|---|
-27.11% | 14.02M | |
+49.21% | 56.87B | |
+36.36% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- CUBT Stock
- News Curative Biotechnology, Inc.
- Curative Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt